Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Elexir Pharma AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 135,004 Less Arrow 107,534 Less Arrow 87,081
Financial expenses 0 More Arrow 11 More Arrow 52
Earnings before taxes 15,711 Less Arrow 12,247 Less Arrow 11,994
EBITDA 15,803 Less Arrow 12,380 Less Arrow 12,175
Total assets 60,801 Less Arrow 45,371 Less Arrow 34,987
Current assets 55,409 Less Arrow 41,840 Less Arrow 34,261
Current liabilities 21,116 Less Arrow 13,111 Less Arrow 9,611
Equity capital 38,308 Less Arrow 30,870 Less Arrow 24,361
- share capital 50 Equal arrow 50 Equal arrow 50
Employees (average) 19 Less Arrow 15 Less Arrow 10

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 63.0% More Arrow 68.0% More Arrow 69.6%
Turnover per employee 7,105 More Arrow 7,169 More Arrow 8,708
Profit as a percentage of turnover 11.6% Less Arrow 11.4% More Arrow 13.8%
Return on assets (ROA) 25.8% More Arrow 27.0% More Arrow 34.4%
Current ratio 262.4% More Arrow 319.1% More Arrow 356.5%
Return on equity (ROE) 41.0% Less Arrow 39.7% More Arrow 49.2%
Change turnover 27,470 Less Arrow 20,453 Less Arrow 5,925
Change turnover % 26% Less Arrow 23% Less Arrow 7%
Chg. No. of employees 4 More Arrow 5 Less Arrow 0
Chg. No. of employees % 27% More Arrow 50% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.